Concepedia

Charity D. Scripture

CD

13

Publications

1.4K

Citations

12

H-Index

2004

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

University of Chicago

AbbVie (United States)

Charity D. Scripture is an author at National Cancer Institute specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

2004–2024

13

Publications

13

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Alex Sparreboom, Charity D. Scripture, Vuong Trieu et al. · Clinical Cancer Research · 2005 · 492 citations · Full text

Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives

Charity D. Scripture, William D. Figg, Alex Sparreboom · Current Neuropharmacology · 2006 · 318 citations · Full text

, , +16

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and<i>nab</i>-Paclitaxel

Erin R. Gardner, William L. Dahut, Charity D. Scripture et al. · Clinical Cancer Research · 2008 · 216 citations · Full text

A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer

William L. Dahut, Charity D. Scripture, Edwin M. Posadas et al. · Clinical Cancer Research · 2008 · 178 citations

Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy

Charity D. Scripture, William D. Figg, Alex Sparreboom · Therapeutics and Clinical Risk Management · 2005 · 80 citations · Full text

Rows per page

1–5 of 13